Anticoagulants Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Anticoagulants Market to 2027 - Global Analysis and Forecasts by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin & Low-Molecular-Weight Heparin (LMWH), Vitamin K Antagonist, Others); Route Of Administration (Oral anticoagulant, Injectable anticoagulant); Application (Atrial fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00004062 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Anticoagulants are used to eradicate the risk of blood clots in the body. The blood clots are formed when platelets stick together and proteins in the blood bind together to form a solid mass. Usually, blood clots play an important role in stopping external bleeding caused by any injury to the skin. The anticoagulants stop the platelets from adhering to one another and clotting proteins from binding together. These are commonly used in the treatment of deep vein thrombosis (DVT), atrial fibrillation, pulmonary embolism and managing high and adequate risk of stroke.

MARKET DYNAMICS
The anticoagulants market is expected to grow during the forecast period due to increasing aging population, RISING investment in R&D in the pharmaceutical sector and the introduction of innovative oral anticoagulants drugs and rising number of mergers & acquisitions of drug manufacturing companies. However, stringent regulations by various governments and risk of side-effects & complications associated with the usage of oral anticoagulants are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global Anticoagulants Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by drug class, route of administration, application, distribution channel and geography. The global anticoagulants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global anticoagulants market is segmented on the basis of drug class, route of administration, application and distribution channel. Based on drug class, the market is classified as novel oral anticoagulants (NOACs), heparin & low-molecular-weight heparin (LMWH), vitamin K antagonist and others. On the basis of route of administration, the market is classified as oral anticoagulant and injectable anticoagulant. On the basis of application, the market is classified as atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE) and others. On the basis of distribution channel, the market is classified as hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anticoagulants market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anticoagulants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anticoagulants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anticoagulants market in these regions.

MARKET PLAYERS
The reports cover key developments in the anticoagulants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from anticoagulants market are anticipated to lucrative growth opportunities in the future with the rising demand for anticoagulants market in the global market. Below mentioned is the list of few companies engaged in the anticoagulants market.

The report also includes the profiles of key anticoagulants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • Aspen Holdings
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • DAIICHI SANKYO COMPANY, LIMITED
  • Portola Pharmaceuticals, Inc.
  • Novartis AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anticoagulants Market - By Drug Class
1.3.2 Anticoagulants Market - By Route of Administration
1.3.3 Anticoagulants Market - By Application
1.3.4 Anticoagulants Market - By Distribution Channel
1.3.5 Anticoagulants Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTICOAGULANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTICOAGULANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTICOAGULANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTICOAGULANTS - GLOBAL MARKET OVERVIEW
6.2. ANTICOAGULANTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NOVEL ORAL ANTICOAGULANTS (NOACS)
7.3.1. Overview
7.3.2. Novel Oral Anticoagulants (NOACs) Market Forecast and Analysis
7.4. HEPARIN & LOW-MOLECULAR-WEIGHT HEPARIN (LMWH)
7.4.1. Overview
7.4.2. Heparin & Low-Molecular-Weight Heparin (LMWH) Market Forecast and Analysis
7.5. VITAMIN K ANTAGONIST
7.5.1. Overview
7.5.2. Vitamin K Antagonist Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL ANTICOAGULANT
8.3.1. Overview
8.3.2. Oral anticoagulant Market Forecast and Analysis
8.4. INJECTABLE ANTICOAGULANT
8.4.1. Overview
8.4.2. Injectable anticoagulant Market Forecast and Analysis
9. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ATRIAL FIBRILLATION & HEART ATTACK
9.3.1. Overview
9.3.2. Atrial fibrillation & Heart Attack Market Forecast and Analysis
9.4. STROKE
9.4.1. Overview
9.4.2. Stroke Market Forecast and Analysis
9.5. DEEP VEIN THROMBOSIS (DVT)
9.5.1. Overview
9.5.2. Deep Vein Thrombosis (DVT) Market Forecast and Analysis
9.6. PULMONARY EMBOLISM (PE)
9.6.1. Overview
9.6.2. Pulmonary Embolism (PE) Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. ANTICOAGULANTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Anticoagulants Market Overview
11.1.2 North America Anticoagulants Market Forecasts and Analysis
11.1.3 North America Anticoagulants Market Forecasts and Analysis - By Drug Class
11.1.4 North America Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.1.5 North America Anticoagulants Market Forecasts and Analysis - By Application
11.1.6 North America Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Anticoagulants Market Forecasts and Analysis - By Countries
11.1.7.1 United States Anticoagulants Market
11.1.7.1.1 United States Anticoagulants Market by Drug Class
11.1.7.1.2 United States Anticoagulants Market by Route Of Administration
11.1.7.1.3 United States Anticoagulants Market by Application
11.1.7.1.4 United States Anticoagulants Market by Distribution Channel
11.1.7.2 Canada Anticoagulants Market
11.1.7.2.1 Canada Anticoagulants Market by Drug Class
11.1.7.2.2 Canada Anticoagulants Market by Route Of Administration
11.1.7.2.3 Canada Anticoagulants Market by Application
11.1.7.2.4 Canada Anticoagulants Market by Distribution Channel
11.1.7.3 Mexico Anticoagulants Market
11.1.7.3.1 Mexico Anticoagulants Market by Drug Class
11.1.7.3.2 Mexico Anticoagulants Market by Route Of Administration
11.1.7.3.3 Mexico Anticoagulants Market by Application
11.1.7.3.4 Mexico Anticoagulants Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Anticoagulants Market Overview
11.2.2 Europe Anticoagulants Market Forecasts and Analysis
11.2.3 Europe Anticoagulants Market Forecasts and Analysis - By Drug Class
11.2.4 Europe Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.2.5 Europe Anticoagulants Market Forecasts and Analysis - By Application
11.2.6 Europe Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Anticoagulants Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Anticoagulants Market
11.2.7.1.1 Germany Anticoagulants Market by Drug Class
11.2.7.1.2 Germany Anticoagulants Market by Route Of Administration
11.2.7.1.3 Germany Anticoagulants Market by Application
11.2.7.1.4 Germany Anticoagulants Market by Distribution Channel
11.2.7.2 France Anticoagulants Market
11.2.7.2.1 France Anticoagulants Market by Drug Class
11.2.7.2.2 France Anticoagulants Market by Route Of Administration
11.2.7.2.3 France Anticoagulants Market by Application
11.2.7.2.4 France Anticoagulants Market by Distribution Channel
11.2.7.3 Italy Anticoagulants Market
11.2.7.3.1 Italy Anticoagulants Market by Drug Class
11.2.7.3.2 Italy Anticoagulants Market by Route Of Administration
11.2.7.3.3 Italy Anticoagulants Market by Application
11.2.7.3.4 Italy Anticoagulants Market by Distribution Channel
11.2.7.4 Spain Anticoagulants Market
11.2.7.4.1 Spain Anticoagulants Market by Drug Class
11.2.7.4.2 Spain Anticoagulants Market by Route Of Administration
11.2.7.4.3 Spain Anticoagulants Market by Application
11.2.7.4.4 Spain Anticoagulants Market by Distribution Channel
11.2.7.5 United Kingdom Anticoagulants Market
11.2.7.5.1 United Kingdom Anticoagulants Market by Drug Class
11.2.7.5.2 United Kingdom Anticoagulants Market by Route Of Administration
11.2.7.5.3 United Kingdom Anticoagulants Market by Application
11.2.7.5.4 United Kingdom Anticoagulants Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Anticoagulants Market Overview
11.3.2 Asia-Pacific Anticoagulants Market Forecasts and Analysis
11.3.3 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Drug Class
11.3.4 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.3.5 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Anticoagulants Market
11.3.7.1.1 Australia Anticoagulants Market by Drug Class
11.3.7.1.2 Australia Anticoagulants Market by Route Of Administration
11.3.7.1.3 Australia Anticoagulants Market by Application
11.3.7.1.4 Australia Anticoagulants Market by Distribution Channel
11.3.7.2 China Anticoagulants Market
11.3.7.2.1 China Anticoagulants Market by Drug Class
11.3.7.2.2 China Anticoagulants Market by Route Of Administration
11.3.7.2.3 China Anticoagulants Market by Application
11.3.7.2.4 China Anticoagulants Market by Distribution Channel
11.3.7.3 India Anticoagulants Market
11.3.7.3.1 India Anticoagulants Market by Drug Class
11.3.7.3.2 India Anticoagulants Market by Route Of Administration
11.3.7.3.3 India Anticoagulants Market by Application
11.3.7.3.4 India Anticoagulants Market by Distribution Channel
11.3.7.4 Japan Anticoagulants Market
11.3.7.4.1 Japan Anticoagulants Market by Drug Class
11.3.7.4.2 Japan Anticoagulants Market by Route Of Administration
11.3.7.4.3 Japan Anticoagulants Market by Application
11.3.7.4.4 Japan Anticoagulants Market by Distribution Channel
11.3.7.5 South Korea Anticoagulants Market
11.3.7.5.1 South Korea Anticoagulants Market by Drug Class
11.3.7.5.2 South Korea Anticoagulants Market by Route Of Administration
11.3.7.5.3 South Korea Anticoagulants Market by Application
11.3.7.5.4 South Korea Anticoagulants Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Anticoagulants Market Overview
11.4.2 Middle East and Africa Anticoagulants Market Forecasts and Analysis
11.4.3 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Drug Class
11.4.4 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.4.5 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Anticoagulants Market
11.4.7.1.1 South Africa Anticoagulants Market by Drug Class
11.4.7.1.2 South Africa Anticoagulants Market by Route Of Administration
11.4.7.1.3 South Africa Anticoagulants Market by Application
11.4.7.1.4 South Africa Anticoagulants Market by Distribution Channel
11.4.7.2 Saudi Arabia Anticoagulants Market
11.4.7.2.1 Saudi Arabia Anticoagulants Market by Drug Class
11.4.7.2.2 Saudi Arabia Anticoagulants Market by Route Of Administration
11.4.7.2.3 Saudi Arabia Anticoagulants Market by Application
11.4.7.2.4 Saudi Arabia Anticoagulants Market by Distribution Channel
11.4.7.3 U.A.E Anticoagulants Market
11.4.7.3.1 U.A.E Anticoagulants Market by Drug Class
11.4.7.3.2 U.A.E Anticoagulants Market by Route Of Administration
11.4.7.3.3 U.A.E Anticoagulants Market by Application
11.4.7.3.4 U.A.E Anticoagulants Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Anticoagulants Market Overview
11.5.2 South and Central America Anticoagulants Market Forecasts and Analysis
11.5.3 South and Central America Anticoagulants Market Forecasts and Analysis - By Drug Class
11.5.4 South and Central America Anticoagulants Market Forecasts and Analysis - By Route Of Administration
11.5.5 South and Central America Anticoagulants Market Forecasts and Analysis - By Application
11.5.6 South and Central America Anticoagulants Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Anticoagulants Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Anticoagulants Market
11.5.7.1.1 Brazil Anticoagulants Market by Drug Class
11.5.7.1.2 Brazil Anticoagulants Market by Route Of Administration
11.5.7.1.3 Brazil Anticoagulants Market by Application
11.5.7.1.4 Brazil Anticoagulants Market by Distribution Channel
11.5.7.2 Argentina Anticoagulants Market
11.5.7.2.1 Argentina Anticoagulants Market by Drug Class
11.5.7.2.2 Argentina Anticoagulants Market by Route Of Administration
11.5.7.2.3 Argentina Anticoagulants Market by Application
11.5.7.2.4 Argentina Anticoagulants Market by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTICOAGULANTS MARKET, KEY COMPANY PROFILES
13.1. BRISTOL-MYERS SQUIBB COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ASPEN HOLDINGS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BAYER AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DAIICHI SANKYO COMPANY, LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PORTOLA PHARMACEUTICALS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NOVARTIS AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol-Myers Squibb Company
2. GlaxoSmithKline plc.
3. Pfizer Inc.
4. Sanofi
5. Aspen Holdings
6. Bayer AG
7. Boehringer Ingelheim International GmbH
8. DAIICHI SANKYO COMPANY, LIMITED
9. Portola Pharmaceuticals, Inc.
10. Novartis AG
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book